Dnca Finance Sells 15,530 Shares of Synopsys, Inc. $SNPS

Dnca Finance cut its holdings in Synopsys, Inc. (NASDAQ:SNPSFree Report) by 42.9% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 20,680 shares of the semiconductor company’s stock after selling 15,530 shares during the quarter. Dnca Finance’s holdings in Synopsys were worth $10,203,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of SNPS. Alpine Bank Wealth Management grew its holdings in Synopsys by 89.3% in the third quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock worth $26,000 after purchasing an additional 25 shares during the period. TFC Financial Management Inc. raised its holdings in shares of Synopsys by 1,250.0% during the third quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock valued at $27,000 after purchasing an additional 50 shares during the period. Millstone Evans Group LLC bought a new position in shares of Synopsys during the 3rd quarter worth about $27,000. SOA Wealth Advisors LLC. bought a new position in shares of Synopsys during the 3rd quarter worth about $28,000. Finally, McIlrath & Eck LLC acquired a new stake in shares of Synopsys in the 3rd quarter valued at about $29,000. 85.47% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Synopsys

In other news, insider Janet Lee sold 250 shares of Synopsys stock in a transaction on Monday, January 12th. The stock was sold at an average price of $530.00, for a total transaction of $132,500.00. Following the sale, the insider directly owned 11,959 shares in the company, valued at $6,338,270. The trade was a 2.05% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Shelagh Glaser sold 3,657 shares of the business’s stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the transaction, the chief financial officer directly owned 17,842 shares in the company, valued at $8,221,058.34. This trade represents a 17.01% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 4,157 shares of company stock valued at $1,945,036. Insiders own 0.56% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the company. Piper Sandler dropped their price target on Synopsys from $520.00 to $430.00 and set a “neutral” rating on the stock in a research note on Thursday, February 26th. Morgan Stanley reissued an “equal weight” rating and issued a $480.00 price objective (down from $550.00) on shares of Synopsys in a research note on Wednesday, February 25th. Citigroup initiated coverage on Synopsys in a report on Monday, November 24th. They set a “buy” rating and a $580.00 price objective for the company. The Goldman Sachs Group set a $600.00 target price on Synopsys and gave the stock a “buy” rating in a research report on Wednesday, February 25th. Finally, KeyCorp lifted their price target on shares of Synopsys from $575.00 to $600.00 and gave the company an “overweight” rating in a research report on Thursday, December 11th. Eight analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $531.00.

Read Our Latest Report on SNPS

Synopsys Stock Performance

Shares of SNPS stock opened at $412.63 on Friday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.36 and a quick ratio of 1.26. The firm has a 50-day moving average of $461.93 and a 200-day moving average of $464.57. Synopsys, Inc. has a one year low of $365.74 and a one year high of $651.73. The company has a market cap of $79.04 billion, a P/E ratio of 64.07, a P/E/G ratio of 3.41 and a beta of 1.15.

Synopsys (NASDAQ:SNPSGet Free Report) last issued its quarterly earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 EPS for the quarter, beating analysts’ consensus estimates of $3.56 by $0.21. The company had revenue of $2.41 billion during the quarter, compared to the consensus estimate of $2.39 billion. Synopsys had a return on equity of 6.83% and a net margin of 13.76%.Synopsys’s revenue was up 65.6% on a year-over-year basis. During the same period last year, the business posted $3.03 earnings per share. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. Equities research analysts forecast that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

Synopsys Company Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Recommended Stories

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.